SYK - Stryker - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8636671013

Orthopedic, Spinal, Surgical, Neurosurgical, Medical, Implant, Equipment

Stryker Corporation is a leading medical technology company that operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The company's Orthopaedics and Spine segment focuses on developing innovative implant products for various orthopaedic and spine procedures, including total joint replacements, trauma and extremities surgeries, and spinal injury treatments. These products include hip, knee, and shoulder implants, as well as cervical and thoracolumbar systems for complex spine and degenerative therapies.

The MedSurg and Neurotechnology segment offers a wide range of medical devices and equipment for various medical specialties. This includes surgical equipment, surgical navigation systems, endoscopic and communication systems, patient handling and emergency medical equipment, and intensive care disposable products. The segment also provides neurosurgical, neurovascular, and craniomaxillofacial implant products, such as minimally invasive endovascular products, orthobiologic and biosurgery products, and craniomaxillofacial implant products.

In addition to its product offerings, Stryker Corporation is committed to improving patient and caregiver safety through its safety technologies. The company sells its products to doctors, hospitals, and other healthcare facilities through a global network of company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. With a rich history dating back to 1941, Stryker Corporation is headquartered in Portage, Michigan, and continues to drive innovation and excellence in the medical technology industry.

As a global leader in medical technology, Stryker Corporation is dedicated to providing innovative solutions that improve patient outcomes and enhance the quality of life. With a strong focus on research and development, the company is constantly pushing the boundaries of medical technology to address the evolving needs of healthcare professionals and patients worldwide.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for SYK - Stryker  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for SYK - Stryker  - Stock Price & Dividends

SYK Stock Overview

Market Cap in USD 126,483m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1988-02-01

SYK Stock Ratings

Growth 5y 56.1
Fundamental 64.9
Dividend 55.9
Rel. Performance vs Sector -0.43
Analysts 4.03/5
Fair Price Momentum 322.67 USD
Fair Price DCF 197.78 USD

SYK Dividends

Dividend Yield 12m 0.95%
Yield on Cost 5y 1.55%
Dividends CAGR 5y 7.39%
Payout Consistency 93.4%

SYK Growth Ratios

Growth 12m 18.39%
Growth Correlation 12m 55%
Growth Correlation 3m 20%
CAGR 5y 10.21%
CAGR/Mean DD 5y 1.25
Sharpe Ratio 12m 0.62
Alpha vs SP500 12m -5.10
Beta vs SP500 5y weekly 1.17
ValueRay RSI 25.30
Volatility GJR Garch 1y 21.13%
Price / SMA 50 -1.93%
Price / SMA 200 3.55%
Current Volume 1680k
Average Volume 20d 1168.4k

External Links for SYK Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of SYK stocks?
As of July 27, 2024, the stock is trading at USD 331.67 with a total of 1,679,993 shares traded.
Over the past week, the price has changed by -2.72%, over one month by -2.37%, over three months by -0.94% and over the past year by +18.22%.
What are the forecast for SYK stock price target?
According to ValueRays Forecast Model, SYK Stryker will be worth about 358.8 in July 2025. The stock is currently trading at 331.67. This means that the stock has a potential upside of +8.17%.
Issuer Forecast Upside
Wallstreet Target Price 378.8 14.2
Analysts Target Price 317.1 -4.40
ValueRay Target Price 358.8 8.17

Stryker Corporation: From Humble Beginnings to Global Leader

Stryker Corporation, globally recognized by its ticker symbol NYSE:SYK, stands out as one of the top-tier medical technology companies worldwide. The company's journey, its diverse product offerings, and its remarkable standing in the current market showcase its dedication to improving healthcare through innovative solutions.

History: The Foundation of Stryker

Stryker's story begins in 1941, with its founder, Dr. Homer Stryker, an orthopedic surgeon frustrated by the limitations of medical equipment available at the time. His inventions, aimed at addressing these challenges, laid the foundation for Stryker Corporation. The company's early focus was on creating products that enhanced patient and hospital outcomes, a core principle that continues to drive its operations.

Core Business: Advancing Medical Technology

At its heart, Stryker specializes in a wide array of medical technologies, including orthopedics, medical and surgical equipment, and neurotechnology and spine products. Its portfolio spans from joint replacement solutions and surgical equipment to neurovascular therapies and advanced wound care. This diverse range of products underscores Stryker's commitment to innovation and its role in supporting healthcare professionals and patients alike.

Side Business: Diversification and Growth

Beyond its primary offerings, Stryker has also strategically expanded into related areas. These include emergency medical services, digital solutions for surgery, and hospital information systems. This diversification not only broadens Stryker's impact across the healthcare sector but also enhances its resilience and adaptability in a constantly evolving market.

Current Market Status: A Leader Among Giants

Today, Stryker's standing in the global medical technology market is both prominent and influential. With a strong growth trajectory, the company continues to deliver on its commitment to innovation, garnering global recognition and a robust financial performance. Stryker's strategic acquisitions and a focus on research and development have further solidified its market position, making it a preferred partner for healthcare facilities and professionals worldwide.